Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VTS-270 Extension Study in Niemann-Pick Type C1
NCT03879655Phase 3Terminated
- Sponsor
- Mandos Health
- Start
- Dec 2019
- Primary completion
- Oct 2021
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Trappsol Cyclo in Niemann-Pick disease type C (NPC), sponsored by Mandos Health. Started Dec 2019; status: terminated.
02
Drugs
Trappsol Cyclo
03
Conditions
Niemann-Pick disease type C (NPC)
Beyond the preview
Go deeper on NCT03879655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03879655.